Margaritis D - Search Results

1

Overexpression of RANKL by invariant NKT cells enriched in the bone marrow of patients with multiple myeloma.

Spanoudakis E, Papoutselis M, Terpos E, Dimopoulos MA, Tsatalas C, Margaritis D, Rahemtulla A, Kotsianidis I, Karadimitris A. Spanoudakis E, et al. Among authors: margaritis d. Blood Cancer J. 2016 Nov 11;6(11):e500. doi: 10.1038/bcj.2016.108. Blood Cancer J. 2016. PMID: 27834938 Free PMC article. No abstract available.

2

Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS).

Kotsianidis I, Bouchliou I, Nakou E, Spanoudakis E, Margaritis D, Christophoridou AV, Anastasiades A, Tsigalou C, Bourikas G, Karadimitris A, Tsatalas C. Kotsianidis I, et al. Among authors: margaritis d. Leukemia. 2009 Mar;23(3):510-8. doi: 10.1038/leu.2008.333. Epub 2008 Nov 20. Leukemia. 2009. PMID: 19020538

3

Dynamics of telomere's length and telomerase activity in Philadelphia chromosome negative myeloproliferative neoplasms.

Spanoudakis E, Bazdiara I, Pantelidou D, Kotsianidis I, Papadopoulos V, Margaritis D, Xanthopoulidis G, Moustakidis E, Mantzourani S, Bourikas G, Tsatalas C. Spanoudakis E, et al. Among authors: margaritis d. Leuk Res. 2011 Apr;35(4):459-64. doi: 10.1016/j.leukres.2010.07.042. Epub 2010 Sep 9. Leuk Res. 2011. PMID: 20828816

4

Statin-induced immunomodulation alters peripheral invariant natural killer T-cell prevalence in hyperlipidemic patients.

Nakou E, Babageorgakas P, Bouchliou I, Tziakas DN, Miltiades P, Spanoudakis E, Margaritis D, Kotsianidis I, Stakos DA. Nakou E, et al. Among authors: margaritis d. Cardiovasc Drugs Ther. 2012 Aug;26(4):293-9. doi: 10.1007/s10557-012-6387-z. Cardiovasc Drugs Ther. 2012. PMID: 22441892 Clinical Trial.

5

Has introduction of azacytidine in everyday clinical practice improved survival in late-stage Myelodysplastic syndrome? A single center experience.

Papoutselis M, Douvali E, Papadopoulos V, Spanoudakis E, Margaritis D, Tsatalas C, Kotsianidis I. Papoutselis M, et al. Among authors: margaritis d. Leuk Res. 2014 Feb;38(2):161-5. doi: 10.1016/j.leukres.2013.10.015. Epub 2013 Oct 28. Leuk Res. 2014. PMID: 24239174

6

Hydroxyurea (HU) is effective in reducing JAK2V617F mutated clone size in the peripheral blood of essential thrombocythemia (ET) and polycythemia vera (PV) patients.

Spanoudakis E, Bazdiara I, Kotsianidis I, Margaritis D, Goutzouvelidis A, Christoforidou A, Tsatalas C, Bourikas G. Spanoudakis E, et al. Among authors: margaritis d. Ann Hematol. 2009 Jul;88(7):629-32. doi: 10.1007/s00277-008-0650-1. Epub 2008 Dec 19. Ann Hematol. 2009. PMID: 19096846 Clinical Trial.

7

Long-term bone marrow cultures (LTBMC) from essential thrombocythemia (ET) patients with or without JAK2617V>F mutation.

Spanoudakis E, Margaritis D, Kotsianidis I, Georgiou G, Tripsianis G, Anastasiadis A, Karakolios A, Pantelidou D, Panayiotidis P, Bourikas G, Tsatalas C. Spanoudakis E, et al. Among authors: margaritis d. Leuk Res. 2008 Oct;32(10):1593-6. doi: 10.1016/j.leukres.2008.01.013. Epub 2008 Mar 5. Leuk Res. 2008. PMID: 18321571

8

Circulating angiopoietin-1 to angiopoietin-2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with novel antimyeloma agents.

Terpos E, Anargyrou K, Katodritou E, Kastritis E, Papatheodorou A, Christoulas D, Pouli A, Michalis E, Delimpasi S, Gkotzamanidou M, Nikitas N, Koumoustiotis V, Margaritis D, Tsionos K, Stefanoudaki E, Meletis J, Zervas K, Dimopoulos MA; Greek Myeloma Study Group, Greece. Terpos E, et al. Among authors: margaritis d. Int J Cancer. 2012 Feb 1;130(3):735-42. doi: 10.1002/ijc.26062. Epub 2011 May 30. Int J Cancer. 2012. PMID: 21484787

9

Pure red cell aplasia as first manifestation of splenic marginal zone lymphoma-successful treatment with rituximab: a case report.

Anastasiadis A, Margaritis D, Kotsianidis I, Spanoudakis E, Christoforidou A, Kostopoulos I, Tsatalas C. Anastasiadis A, et al. Among authors: margaritis d. Cases J. 2009 Aug 18;2:6913. doi: 10.4076/1757-1626-2-6913. Cases J. 2009. PMID: 19918496 Free PMC article.

10

CD1d expression as a prognostic marker for chronic lymphocytic leukemia.

Anastasiadis A, Kotsianidis I, Papadopoulos V, Spanoudakis E, Margaritis D, Christoforidou A, Gouliamtzi S, Tsatalas C. Anastasiadis A, et al. Among authors: margaritis d. Leuk Lymphoma. 2014 Feb;55(2):320-5. doi: 10.3109/10428194.2013.803222. Epub 2013 Jul 8. Leuk Lymphoma. 2014. PMID: 23668820

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters